Raghu Prasad Mailavaram

Raghu Prasad Mailavaram

Auto-generated profile, based on publicly available information

Raghu Prasad Mailavaram

Pharmaceutical Chemistry Division, Sri Vishnu College of Pharmacy, Bhimavaram, India

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Open access
Katharigatta VenugopalaKatharigatta Venugopala
Katharigatta Venugopala
Sandeep ChandrashekharappaSandeep Chandrashekharappa
Sandeep Chandrashekharappa
PDPran Kishore Deb
Pran Kishore Deb
CTChristophe Tratrat
Christophe Tratrat
MPMelendhran Pillay
Melendhran Pillay
RMRaghuprasad Mailavaram
Raghuprasad Mailavaram
A series of 1,2,3-trisubstituted indolizines (2a–2f, 3a–3d, and 4a–4c) were screened for in vitro whole-cell anti-tubercular activity against the susceptible H37Rv and multidrug-resistant (MDR) Mycobacterium tuberculosis (MTB) strains. Compounds 2b–2d, 3a–3d, and 4a–4c were active against the H37Rv-MTB strain with minimum inhibitory concentration (MIC) ranging from 4 to 32 µg/mL, whereas the indolizines 4a–4c, with ethyl ester group at the 4-position of the benzoyl ring also exhibited anti-MDR-MTB activity (MIC = 16–64 µg/mL). In silico docking study revealed the enoyl-acyl carrier protein reductase (InhA) and anthranilate phosphoribosyltransferase as potential molecular targets for the indolizines. The X-ray diffraction analysis of the compound 4b was also carried out. Further, a safety study (in silico and in vitro) demonstrated no toxicity for these compounds. Thus, the indolizines warrant further development and may represent a novel promising class of InhA inhibitors and multi-targeting agents to combat drug-sensitive and drug-resistant MTB strains.

7 May 2020 in Antibiotics
Verified
Journal Article
Open access
PDF file
Katharigatta VenugopalaKatharigatta Venugopala
Katharigatta Venugopala
VIJAYAKUMAR UPPARVIJAYAKUMAR UPPAR
VIJAYAKUMAR UPPAR
Sandeep ChandrashekharappaSandeep Chandrashekharappa
Sandeep Chandrashekharappa
HAHassan H. Abdallah
Hassan H. Abdallah
MPMelendhran Pillay
Melendhran Pillay
BPBasavaraj Padmashali
Basavaraj Padmashali
A series of ethyl 1-(substituted benzoyl)-5-methylpyrrolo[1,2-a]quinoline-3-carboxylates 4a–f and dimethyl 1-(substituted benzoyl)-5-methylpyrrolo[1,2-a]quinoline-2,3-dicarboxylates 4g–k have been synthesized and evaluated for their anti-tubercular (TB) activities against H37Rv (American Type Culture Collection (ATCC) strain 25177) and multidrug-resistant (MDR) strains of Mycobacterium tuberculosis by resazurin microplate assay (REMA). Molecular target identification for these compounds was also carried out by a computational approach. All test compounds exhibited anti-tuberculosis (TB) activity in the range of 8–128 µg/mL against H37Rv. The test compound dimethyl-1-(4-fluorobenzoyl)-5-methylpyrrolo[1,2-a]quinoline-2,3-dicarboxylate 4j emerged as the most promising anti-TB agent against H37Rv and multidrug-resistant strains of Mycobacterium tuberculosis at 8 and 16 µg/mL, respectively. In silico evaluation of pharmacokinetic properties indicated overall drug-likeness for most of the compounds. Docking studies were also carried out to investigate the binding affinities as well as interactions of these compounds with the target proteins.

1 December 2020 in Tuberculosis
Verified
Journal Article
Closed access
STSamanvai Reddy Tetali
Samanvai Reddy Tetali
EKEswar Kunapaeddi
Eswar Kunapaeddi
RMRaghu Prasad Mailavaram
Raghu Prasad Mailavaram
VSVinayak Singh
Vinayak Singh
PBPobitra Borah
Pobitra Borah
RTRakesh Kumar Tekade
Rakesh Kumar Tekade

10 June 2021 in Molecules
Verified
Journal Article
Open access
PDF file
Katharigatta VenugopalaKatharigatta Venugopala
Katharigatta Venugopala
Sandeep ChandrashekharappaSandeep Chandrashekharappa
Sandeep Chandrashekharappa
CTChristophe Tratrat
Christophe Tratrat
PDPran Kishore Deb
Pran Kishore Deb
RNRahul Dharmaji Nagdeve
Rahul Dharmaji Nagdeve
YIYasmine F. Ibrahim
Yasmine F. Ibrahim
The cyclooxygenase-2 (COX-2) enzyme is an important target for drug discovery and development of novel anti-inflammatory agents. Selective COX-2 inhibitors have the advantage of reduced side-effects, which result from COX-1 inhibition that is usually observed with nonselective COX inhibitors. In this study, the design and synthesis of a new series of 7-methoxy indolizines as bioisostere indomethacin analogues (5a–e) were carried out and evaluated for COX-2 enzyme inhibition. All the compounds showed activity in micromolar ranges, and the compound diethyl 3-(4-cyanobenzoyl)-7-methoxyindolizine-1,2-dicarboxylate (5a) emerged as a promising COX-2 inhibitor with an IC50 of 5.84 µM, as compared to indomethacin (IC50 = 6.84 µM). The molecular modeling study of indolizines indicated that hydrophobic interactions were the major contribution to COX-2 inhibition. The title compound diethyl 3-(4-bromobenzoyl)-7-methoxyindolizine-1,2-dicarboxylate (5c) was subjected for single-crystal X-ray studies, Hirshfeld surface analysis, and energy framework calculations. The X-ray diffraction analysis showed that the molecule (5c) crystallizes in the monoclinic crystal system with space group P 21/n with a = 12.0497(6)Å, b = 17.8324(10)Å, c = 19.6052(11)Å, α = 90.000°, β = 100.372(1)°, γ = 90.000°, and V = 4143.8(4)Å3. In addition, with the help of Crystal Explorer software program using the B3LYP/6-31G(d, p) basis set, the theoretical calculation of the interaction and graphical representation of energy value was measured in the form of the energy framework in terms of coulombic, dispersion, and total energy.

1 May 2010 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
BSB. Sirisha
B. Sirisha
BNB. Narsaiah
B. Narsaiah
TYT. Yakaiah
T. Yakaiah
GGG. Gayatri
G. Gayatri
GSG. Narahari Sastry
G. Narahari Sastry
ARA. Raghuram Rao
A. Raghuram Rao

15 April 2019 in Chemical Biology & Drug Design
Verified
Journal Article
Closed access
PDF file
KSKhasim Shaik
Khasim Shaik
PDPran Kishore Deb
Pran Kishore Deb
RMRaghu Prasad Mailavaram
Raghu Prasad Mailavaram
BCBalakumar Chandrasekaran
Balakumar Chandrasekaran
SKSonja Kachler
Sonja Kachler
AJAbdul Muttaleb Yousef Jaber
Abdul Muttaleb Yousef Jaber